NanoCellect's mission is to facilitate biomedical breakthroughs by making cell analysis and sorting technology more affordable and easier to use. Our microfluidic flow cytometry platforms enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, and basic research. The company was founded in late 2009 as a spinout from UCSD and dedicated 6 years developing the foundation of the WOLF's technology before launching the WOLF (our first product) in 2016. Initial funding of R&D was graciously funded by multiple NIH SBIR grants and contracts and recently backed by FusionX Ventures and other private investors.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $46.8M
Founded date: 2009
Investors 8
Funding Rounds 3
| Date | Series | Amount | Investors |
| 24.08.2022 | Grant | $1.8M | - |
| 25.10.2021 | Series C | $35M | - |
| 01.12.2017 | Series B | $10M | - |
Mentions in press and media 16
| Date | Title | Description |
| 03.01.2026 | Understanding Single-Cell Research: Unlocking the Secrets of Our Cells | Share Share Share Share Email Have you ever stopped to consider what makes each cell unique in your body? It can be truly astounding when we stop to consider it; every cell tells its own individual tale. Single-cell research seeks to discov... |
| 24.08.2022 | NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies | We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT |
| 24.08.2022 | NanoCellect Biomedical receives $1.8M in federal grant funding to advance imaging flow cytometry | - |
| 25.10.2021 | NanoCellect Rakes In $35M in Series C and D funding that will be used to grow the team and support R&D and projects | - |
| 25.10.2021 | NanoCellect Raises $35M | Photo Courtesy of NanoCellect The proceeds from NanoCellect’s $35 million funding rounds will support the development and launch of its second-generation WOLF G2 cell sorting system. NanoCellect Biomedical, Inc. brought in $35 million in Se... |
| 16.09.2021 | NanoCellect accelerates growth plans with close of $35 Million in Series C & D Rounds led by Vertical Venture Partners and Warburg Pincus | |
| 16.09.2021 | NanoCellect accelerates growth plans with close of $35 Million in Series C & D Rounds led by Vertical Venture Partners and Warburg Pincus | We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT |
| 13.05.2021 | NanoCellect Biomedical Reinvents the Cell Sorter with the WOLF G2 | |
| 20.08.2020 | NanoCellect Biomedical Expands its Global Distribution Network | |
| 04.12.2017 | Term Sheet — Monday December 4 | 5 Qs WITH A DEALMAKER Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop He’s the man behind Tusk Ventures, a political consultancy and venture firm that works with startups facing regulatory hu... |
Show more